These include feeling nauseated, vomiting, diarrhea, upset stomach, headache, dizziness and a complete loss of appetite
Metabolic Balance & Energy
Based on the strength of the clinical data, we expect Wegovy to be added to formularies with utilization management restrictions for prior authorization to prevent off-label use, shorter initial approval periods (e.g., six months approved initially) to ensure efficacy, and quantity limits to reduce stockpiling and waste
At the same time, the large number of obese patients preferred its use
Browse all Peptides & GLP-1 education Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims